During the past decade, DermResearch, Inc. conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 52 clinical trials were completed, i.e. on average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 23 clinical trials were completed. i.e. 135.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DermResearch, Inc." #1 sponsor was "Galderma R&D" with 18 trials, followed by "Allergan" with 8 trials sponsored, "DUSA Pharmaceuticals, Inc." with 6 trials sponsored, "Dow Pharmaceutical Sciences" with 5 trials sponsored and "Peplin" with 5 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DermResearch, Inc." #1 collaborator was "GlaxoSmithKline" with 5 trials as a collaborator, "Derm Research, PLLC" with 3 trials as a collaborator, "ClinDatrix, Inc." with 2 trials as a collaborator, "Clinical Trials of Texas, Inc." with 2 trials as a collaborator and "Progressive Clinical Research" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "DermResearch, Inc." are "Acne Vulgaris" (25 trials), "Actinic Keratosis" (11 trials), "Atopic Dermatitis" (11 trials), "Plaque Psoriasis" (10 trials) and "Psoriasis" (9 trials). Many other conditions were trialed in "DermResearch, Inc." in a lesser frequency.

Most popular intervention types in "DermResearch, Inc." are "Drug" (124 trials), "Other" (10 trials), "Device" (7 trials), "Biological" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Vehicle" (20 trials), "Vehicle Gel" (4 trials), "122-0551" (2 trials) and "A-101" (2 trials). Other intervention names were less common.

The vast majority of trials in "DermResearch, Inc." are 130 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "DermResearch, Inc.". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 122 completed trials in DermResearch, Inc., 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in DermResearch, Inc., 15 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 3 trials that are defined as “Not Applicable".